{
  "id": 543100,
  "title": "Earnings call transcript: Wallenius Wilhelmsen lifts 2026 outlook in Q2 2026",
  "url": "https://urgent.news/2026/08/11/earnings-call-transcript-wallenius-wilhelmsen-lifts-2026-outlook-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-11T07:37:04.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-wallenius-wilhelmsen-lifts-2026-outlook-in-q2-2026-93CH-4850872"
  },
  "original_language": "en",
  "account": "Wallenius Wilhelmsen reported solid Q2 2026 results, with $1.3 billion in revenue, slightly below the $1.32 billion forecast. Adjusted EBITDA was $361 million, and net profit was $138 million. The company raised its full-year EBITDA outlook to $1.7 billion. Shipping volumes increased, particularly ex-West due to seasonal patterns, while total revenue reached $1.3 billion. Higher bunker costs weighed on margins and cash flow, causing adjusted EBITDA to slip. Wallenius Wilhelmsen is a major vehicle carrier, with its fleet out of Asia fully sold out. Demand from Chinese automakers is unusually strong, with Chinese brands now viewed as preferred products in many markets. The company's logistics services posted their strongest result in about five years, and government services improved modestly. Despite pressure from bunker costs and lower freight rates on some western routes, the mixed but generally strong quarter showed progress outside core shipping. The stock rose 1.23% to $148.5 in premarket trading. For more detailed insights, investors can access the comprehensive Pro Research Report on InvestingPro.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up",
        "url": "https://urgent.news/2026/08/10/earnings-call-transcript-bionano-genomics-tops-q2-revenue-view-shares",
        "published": "2026-08-10T21:05:27.000Z"
      },
      {
        "outlet": "Seeking Alpha News",
        "title": "Bionano outlines $31M-$33M 2026 revenue forecast amid flow cell supply constraints",
        "url": "https://urgent.news/2026/08/10/bionano-outlines-31m-33m-2026-revenue-forecast-amid-flow-cell-supply",
        "published": "2026-08-10T22:39:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}